chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 10:15, writer arrived to resident's home. Resident made writer aware she was allergic to PNC and had a hx of seizure. Writer continued registration process and flagged for 30 minute observation. Resident then received 1st dose of pfizer. Less than two minutes shortly after vaccine was administered resident verbalized that she was feeling numb starting from her throat and moving down her chest. She denied having SOB, was alert and responding to my questions. At 10:35 patient started gasping for air holding her throat. Epi pen was immediately administered to thigh and was not effective. Resident began to seize lasting for about 5 minutes. 911 called at 10:43 am. Resident turned on side resident continue gasping and started seizing again. All safety measures in place. At 10:50 am, 911 staff arrived provided and took resident to the hospital.
Received flu vaccination 1:30 PM 10/25/02, that evening felt sore and dizzy, Today 100 fever dizzy, ache, tired. took tylenol 4pm still dizzy sore
immunization reaction ldt redden area. mom advised to put cool packs on affected area. return to clinic if worsens.
2/7-2/9: pain at injection site 2/9-current: left shoulder and arm pain constant throughout the day. Ibuprofen 800mg taken on most days 2/15-2/16: sporadic chest pain and tightness on left side of chest
9 days after the vaccine I experienced a swollen red lymph node in my left armpit. (site arm) The node continued to swell and be tender until it was the size of a ping pong ball. 33 days after the injection it broke open and tan-ish bloody fluid came out. The doctor instructed if the pain was feeling better continue to clean it and monitor. It appears to be healing but as of right now I still have a red enlarged area under my armpit and it has been 38 days since my vaccine.
Information has been received from a health professional concerning a 16 year old female who on approximately 19-FEB-2008 was IM vaccinated with Gardasil (lot number unspecified).  The physician advised the patient to "sit for about 15 minutes", but the patient got up about 5 minutes after being vaccinated in order to make another appointment.  On approximately 19-FEB-2008 the patient passed out at the appointment desk shortly after administration.  Subsequently, the patient recovered before leaving the office.  No further information was provided.  No lot number was given.  Additional information has been requested.
Pt reports 3" long x 1 1/2" wide red area at injection site & itching on 1/26; on 1/27 pt reports additional blisters at injection site.  Went to walk in clinic on 1/26 & started on Benadryl 25 mg po q 6 hours & cortisone cream.  Saw MD at church on 1/27 & started on acyclovir 800 mg po q 4 hours x7 days.
Received 2nd dose of Pfizer COVID vaccine on 1/24/2021.   On 4/12/2021 the patient developed body aches, cough, headache, and nasal congestion.  Positive for COVID.
No adverse symptoms reported; a patient was administered VARIVAX by the intramuscular route; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.  On 15-NOV-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (strength and dose were not reported; lot # R017637, expiration date 20-JUL-2020) by the intramuscular route (incorrect route of product administration) for prophylaxis.  No adverse symptoms were reported.
Hot, swollen, painful arm (entire upper arm) at injection site. HC 2.5% cream/ice.
Blood clots, right leg, diagnosed with ultrasound. Pain, swelling, redness of right foot and leg.
No adverse events; Inadvertently administered a dose of proquad via the intramuscular route rather than the subcutaneous route; This spontaneous report was received from a nurse refers to a 4-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not reported. Concomitant therapies included sterile diluent.   On 11-DEC-2019, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, dose number and anatomical location were not reported) lot # R030801 with expiration date: 22-APR-2020; via intramuscular route rather than the subcutaneous route for prophylaxis (incorrect route of product administration). No adverse symptoms reported (no adverse event). No product quality complaint (PQC) was involved.
I tested positive for COVID-19 2 weeks postpartum following being fully vaccinated. I had severe symptoms that included a fever of 103F. I was told by my doctor to get monoclonal antibody treatment, which was completed on 12/29/2021. My 2-week-old daughter tested positive for COVID-19 a week later. Over the last 3 months, I have had 2 sinus infections. My daughter has had to have 5 medical appointments and is now being referred to a specialist to treat her post-COVID symptoms, which include ongoing congestion, an inability to lie flat in her crib, sneezing, and coughing. This has affected me financially, now that the treatments for COVID-19 are no longer given for free. Not only that, but the coughing I experienced during my illness caused me to tear the vaginal stitches I had received after giving birth. I had to go the emergency room as a result  and to a follow-up appointment to get medication. Of course, this has incurred further cost.
pain; Non-sexually transmitted severe genital sores; genital aphthous ulcers of unknown etiology with consequent severe dysuria; genital aphthous ulcers of unknown etiology with consequent severe dysuria; This is a spontaneous report from a contactable physician, the patient. A 37-years-old  female patient (physician) received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EK9231), via an unspecified route of administration 13Jan2021  as a single dose  for COVID-19 vaccination. It was Unknown if the patient was pregnant at Time of Vaccination. The facility in which the vaccination was administered was a Hospital. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medication included Vitamins. No other vaccines were given within 4 weeks. Since the vaccination the patient had not been tested for COVID-19.  On 14Jan2021 at 22:15, The patient experienced non-sexually transmitted severe genital sores/genital aphthous ulcers of unknown etiology with consequent severe dysuria, pain, disabling from walking, sitting.  The adverse events resulted in a physician's office/clinic visit.  No treatment was given for the events. The clinical outcome of the events non-sexually transmitted severe genital sores/genital aphthous ulcers, severe dysuria, pain, disabling from walking, sitting was not recovered.
Pt received Pneumovax left deltoid, IM on 11/08/2001. 4.5 to 5 hours later after injection pt experienced swelling, erythema and numbness in left arm with pain. Approximately 12 hours after injection, pt experienced an asthma attack. Pt used her "inhaler" and symptoms improved.
4 days after the MMR and VARIVAX, left arm developed swelling, pain and fever.  Steroid shots on 8/14/08 and on Sept 2, 08 and treated for Cellulitis left deltoid.  Antibiotics, Augmentin and Rocephin.
Developed upper extremity paresthesias on 5/22 that progressed to lower extremities. Concern for worsening respiratory status. CSF studies consistent with Guillain Barre Syndrome. Received 5 doses IVIG. Improving neuro exam. Discharged on 6/5/17 to inpatient rehabilitation unit.
depression; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEPRESSION (non-serious), outcome "unknown", described as "depression".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021481483 same reporter/drug, similar AE, different patient;US-PFIZER INC-2021481530 same reporter/drug, similar AE, different patient
The evening of 12/16 my headache begin at the next day fever of 103 stayed for 7 hrs took  administered Tylenol  exp chills, body aches, and rash on face around the eye spread to right side of nose, side went to hand area lasted from 12/17 to 12/21.The headache started effecting my neck contacted my PCP on 12/19. I went to ER on 12/19 ran tests CT scan check for clots negative, lumbar puncture and chest X-ray was fine and dint exp respiratory problems. I missed 3 days of from work 12/9 to 12/21.
This spontaneous report was received from a certified medical assistant, referring to a patient of unknown age and gender. The patient concurrent condition and medical history were unknown. On 19-NOV-2015 the patient was vaccinated with an improperly stored dose of M-M-R II (Lot # K024036, expiration date 26-NOV-2016) (dose, administration route and anatomical site of administration were unknown). No concomitant therapies or adverse events were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
On 01/27/2021, I received my second dose of the Moderna vaccine, as I got to my car after, I started having chest pain, heart fluttering and arm pain/numbness and tingling. And headache. I went to the ER that evening and had an ekg and some blood work. I was given some meds for my headache. The ekg was abnormal so I was told to have a stress echo test done. On 02/11/2021, I had the stress echo of my heart and it was abnormal. My blood pressure also went to over 200. I was told to have a cardiac catheterization. I had the catheterization scheduled but on 02/12/2021 I was having chest pain and arm pain/numbness and tingling again so I went to the ER at a different hospital. I had an ekg upon entering and since it was abnormal I was seen by ER doctors who determined I needed to be admitted to the cardiac ICU to be monitored over night and also to have the cardiac catheterization the next day. I had the catheterization on 02/13/2021, however, no blockage was found. I continue to have severe headaches, chest pain, and heart fluttering.
I was feeling feverish and lousy, I took an at home COVID-19 test and it was positive. I had body aches, headache and feverish. I called my doctor and they prescribed PAXLOVID. After taking that a few days later I started to fell better, just a little tired.
lost their babies; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP), Program ID:  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: ABORTION SPONTANEOUS (medically significant), outcome "unknown", described as "lost their babies".  Clinical course: caller reported that he is reporting that the Pfizer COVID 19 Vaccine is causing cancer to everyone. The caller mentioned there were four girls who got the vaccine, and three of them lost their babies. The caller also mentioned that one of his friends took the shot and had a massive heart attack. They also recently found out they have stage 4 cancer of the prostate. The caller also mentioned that (withheld), after getting the shot, had COVID twice already. The caller also mentioned that a boy got the vaccine and died afterwards.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
reaction progressed to swelling in the whole left leg; the reaction progressed; soreness; irritability; purplish, reddish not raised rash; vasculitis-like reaction; This is a spontaneous report received from a contactable reporter(s) (Nurse) from medical information team.  A 10-month-old female patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), as dose 2, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Prevnar 13 (DOSE NUMBER 1, SINGLE), for Immunization, reaction(s): "local reaction with redness, red dots and tenderness in her left thigh", "local reaction with redness, red dots and tenderness in her left thigh", "local reaction with redness, red dots and tenderness in her left thigh", "local reaction with redness, red dots and tenderness in her left thigh". The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "reaction progressed to swelling in the whole left leg"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "the reaction progressed"; PAIN (non-serious), outcome "unknown", described as "soreness"; INFANT IRRITABILITY (non-serious), outcome "unknown", described as "irritability"; RASH (non-serious), outcome "unknown", described as "purplish, reddish not raised rash"; VASCULITIS (non-serious), outcome "unknown", described as "vasculitis-like reaction".  Additional information: It was reported that, call is regarding a ten-month-old female patient. Reporter referred that when the patient got their 2-month dose of Prevnar 13, had what was deemed a local reaction with redness, red dots and tenderness in her left thigh within 24 hours. When the patient got their 4-month dose of Prevnar the reaction progressed to swelling in the whole left leg, soreness, irritability and a purplish, reddish not raised rash. Reporter defined it as vasculitis-like reaction. Had been holding off the patients third dose due to the reactions and wants to know if something like what the patient experienced has been reported and if there is any recommendation. Pfizer is unable to make any medical recommendations for individual patients.  The information on the batch/lot number for pneumococcal 13-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300004981 Same patient and drug, event separated in time;
DIZZINESS; SHINGLES; EXTREME NAUSEA; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced dizziness, shingles, and extreme nausea. The action taken with covid-19 vaccine  was not applicable. The outcome of the extreme nausea, dizziness and shingles was not reported. This report was non-serious.
No additional AEs; Caller reporting temperature excursion for VARIVAX.; This spontaneous report was received from registered nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-MAY-2022, varicella virus vaccine live (oka/merck) (VARIVAX) experienced a temperature excursion of 9 to 25 degree Celsius (14.5 degree Celsius) for 2 hours and -14 up to -10 degree Celsius (-11.49 degree Celsius) for 2 hours. On 01-JUN-2022, improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, lot #T027305 was confirmed to be valid, expiration date was reported as 31-AUG-2022 but upon internal validation established as 12-AUG-2022 (exact dose, route of administration and anatomical location were not provided) for prophylaxis (product storage error). No additional reports was reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2208USA006061:
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 71 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 19-SEP-2021) dose was not reported, administered on 21-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20211136159.
This spontaneous report as received from a licensed practical nurse refers to a 4 month old male patient. The patient had no concomitant medications and no drug reactions or allergies. On 29-JUN-2016, the patient was vaccinated with ROTATEQ oral solution, lot # reported as M005733, expiry date 20-JAN-2017 (dose was not specified). Other suspect therapies included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid, hib conj vaccine (unspecified carrier), poliovirus vaccine and PREVNAR, administered on the same day. On 29-JUN-2016, the patient instantaneously vomited after receiving ROTATEQ, The patient sought medical attention in the office at the time of the event. No treatment was given. No lab diagnostics were performed. The outcome of the event and the causality assessment were not provided. This is one of several reports received from the same reporter. Additional information has been requested.
t100-101 JUL94 rash 4PM; seen by MD had erythematous macular lesions w/restricted raised papular areas on .5-1cm in diameter; pt given DPT;
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Stiffness of shoulder/neck area-Medium, Additional Details: Patient stated shortly after the vaccine her arm became red and swollen from elbow up and she had stiffness in the neck and shoulder area. The redness and swelling resolved, however she still has mobility issues in the arm and shoulder consistently.
All three doses (2+ booster) of the Moderna Covid-19 vaccine caused significant relapse/resurgence of symptoms from CIDP - numbness, weakness, difficulty in mobility. Reporting because people with demylenating illnesses were excluded from vaccine trials so might be helpful for some patients to know.
Injection site: Bright Redness 2 inches in diameter, hardness, moderate pain, itching ; malaise; nausea; vomiting x 1; headache; chills; low-grade fever; myalgia; fatigue
Pt recvd 3 Hepatitis-B vax on 27JUL89, 29AUG89, & 23JAN90 following these titer=12; one yr later titer was neg; pt was given a 4th dose of vax & titer=159;
sore arm after initial series; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after initial series) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Lung disorder NOS (Lungs problem). Concomitant products included VITAMIN D NOS and VITAMIN B NOS for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (sore arm after initial series). In 2021, PAIN IN EXTREMITY (sore arm after initial series) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient has a tracheotomy on their neck Concomitant medications includes medication for sugar, medication for high blood pressure, four different inhalers for lung problems. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-405078, MOD-2021-405079 (Patient Link).
Injection site pain; This is a spontaneous report received from contactable reporter(s) (Pharmacist). The reporter is the patient.  A 52 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 28Aug2021 15:00 (Batch/Lot number: unknown) at the age of 52 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "allergic rhinitis (severe)" (unspecified if ongoing), notes: other medical history: allergic rhinitis (severe); "asthma" (unspecified if ongoing); "sarcoidosis" (unspecified if ongoing); "known allergies: possibly some IV contrast dyes" (unspecified if ongoing), notes: known allergies: possibly some IV contrast dyes; "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19?:Yes. The patient took concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "Injection site pain".  Additional information:Prior to vaccination, the patient was diagnosed with COVID-19, Since the vaccination, has the patient been tested for COVID-19?:No  The Lot number for BNT162b2 was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow-up (22Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected
Pt recv vax on 4/1/99; 10 min post vax pt fell back onto floor, fixed/ dilated pupils, shallow breathing, diaphoretic, difficult palpate of pulse
Shot administered 9-6-10 but both arms got sore and are slowly getting better (9-22-10).
Starting 18-24 hours after recieving the 2nd dose, patient is reporting redness at the injection site that has spread to within 6 inches of elbow and continues to extend laterally around the bicep area.  Patient describes the area as warm to the touch  and raised without out any symptoms of itching. Patient has taken diphenhydramine and applied a cold compress to area with no relief of symptoms. and continued spread of redness.  Patient was advised to follow up with Primary Care Provider for follow-up.
The day after my second dose, on 2/18/21, I felt very sick in the usual ways I had heard about (headache, severe body aches, etc.) but then around noon I had a strange reaction. My whole body started tingling like when your foot falls asleep, but it got stronger and stronger until it felt like a rumbling throughout my whole body.  That continued, and then I noticed my hands were both in an odd position.  Some of my fingers were curled and some were straight, but all of them (and my thumbs) were rigid. I couldn't move any of my fingers, thumb, or my hands. They looked like they were cramping up, but it didn't feel like a cramp. It didn't hurt at all. My husband took me to the Urgent Care after my sister who's a nurse recommended I go. (Still the same day - 2/18/21.) The rigidity continued until after my visit to the urgent care and the pharmacy, where Doctor prescribed some muscle relaxants. I took one and the rigidity gradually loosened and went away. My hands were rigid for around 3 hours total.
Shingles flank pain followed by typical left flank rash with resolution over 4 week time course.  Neurasthesias resolved  over 7 weeks
Very hot, flush, stomach upset, sweating, increased respiratory rate, slouched in chair, chills over face/neck